{"id":734809,"date":"2025-03-06T13:54:02","date_gmt":"2025-03-06T13:54:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=734809"},"modified":"2025-03-06T13:54:02","modified_gmt":"2025-03-06T13:54:02","slug":"infectious-disease-diagnostics-market-worth-315-billion-by-2028-marketsandmarkets","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/infectious-disease-diagnostics-market-worth-315-billion-by-2028-marketsandmarkets_734809.html","title":{"rendered":"Infectious Disease Diagnostics Market worth $31.5 billion by 2028 | MarketsandMarkets"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/upload\/2025\/03\/1741252711.jpg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Infectious Disease Diagnostics Market worth $31.5 billion by 2028 | MarketsandMarkets\" src=\"https:\/\/www.abnewswire.com\/upload\/2025\/03\/1741252711.jpg\" alt=\"Infectious Disease Diagnostics Market worth $31.5 billion by 2028 | MarketsandMarkets\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>North America is well-established, with the US being a major market in this region. This dominance can be attributed to various factors, including advanced healthcare infrastructure, a high prevalence of infectious diseases, and significant investments in diagnostic technologies.<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Diseases such as tuberculosis, HIV\/AIDS, hepatitis, sexually transmitted infections, and respiratory infections require an accurate and timely diagnosis for effective treatment and control. Early diagnosis of these diseases plays a crucial role in the monitoring of these infectious diseases, driving the growth of the market in this area.<\/div>\n<p style=\"text-align: justify;\"><strong>Infectious Disease Diagnostics Market &#8211; Global Forecast to 2028<\/strong><\/p>\n<p style=\"text-align: justify;\">The <strong>Infectious Disease Diagnostics Market<\/strong> is projected to grow from an estimated <strong>USD 21.4 billion in 2023<\/strong> to <strong>USD 31.5 billion by 2028<\/strong>, representing a <strong>CAGR of 8.0%<\/strong> during the forecast period.<\/p>\n<p style=\"text-align: justify;\">The report covers key segments, including <strong>Product &amp; Service (Reagents, Kits), Test Type (Lab, Point-of-Care), Sample Type (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT)<\/strong>, and <strong>Diseases (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Influenza)<\/strong>.<\/p>\n<p style=\"text-align: justify;\">Explore <strong>172 market data tables and 53 figures<\/strong> across <strong>309 pages<\/strong>, offering comprehensive insights into this rapidly evolving market.<strong>View the detailed table of contents here:<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/infectious-disease-diagnostics-market-116764589.html\" rel=\"noopener\" target=\"_new\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/infectious-disease-diagnostics-market-116764589.html<\/a><\/p>\n<p style=\"text-align: justify;\">Key Insights from the Report<\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p><strong>Reagents, Kits &amp; Consumables Lead the Market:<\/strong>In 2022, the <strong>reagents, kits, and consumables segment<\/strong> held the largest market share in the <strong>product &amp; service<\/strong> category. This dominance is driven by the recurring need for these products compared to instruments, ensuring consistent demand from diagnostic labs and healthcare providers.<\/p>\n<\/li>\n<li>\n<p><strong>Blood, Serum &amp; Plasma Samples Dominate Sample Type Segment:<\/strong>Among sample types, <strong>blood, serum, and plasma<\/strong> accounted for the largest share in 2022. These sample types offer a rich source of diagnostic biomarkers, including <strong>DNA, RNA, proteins, and other indicators<\/strong>, making them invaluable for accurate disease detection and monitoring.<\/p>\n<\/li>\n<li>\n<p><strong>North America is the Leading Regional Market:<\/strong>In 2022, <strong>North America<\/strong> led the global infectious disease diagnostics market, with the <strong>US<\/strong> being the largest contributor. This leadership stems from <strong>advanced healthcare infrastructure, high disease prevalence<\/strong>, and <strong>substantial investments in diagnostic technologies<\/strong>.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Key Players in the Market<\/p>\n<p style=\"text-align: justify;\">Leading companies operating in this market include:<strong>Abbott (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche (Switzerland), bioM&eacute;rieux (France), Siemens Healthineers (Germany), Danaher (US), Hologic (US), Becton, Dickinson and Company (US), Revvity (US), QIAGEN (Netherlands), Seegene (South Korea), Grifols (Spain), DiaSorin (Italy), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), QuidelOrtho Corporation (US), Meridian Bioscience (US), Genetic Signatures (Australia), OraSure Technologies (US), Trinity Biotech (Ireland), Chembio Diagnostics (US), Co-Diagnostics (US), ELITech Group (France), Epitope Diagnostics (US), Trivitron Healthcare (India), Meril Life Sciences (India), InBios International (US), Vela Diagnostics (Singapore), and Uniogen Oy (Finland).<\/strong><\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/speaktoanalystNew.asp?id=116764589\" target=\"_blank\"><strong>Don&rsquo;t miss out on growth opportunities in the Infectious Disease Diagnostics Market. Talk to our analysts for valuable industry insights to drive your business forward.<\/strong><\/a><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_145966.html\" rel=\"nofollow\">MarketsandMarkets\u2122 Research Private Ltd.<\/a><br \/><strong>Contact Person:<\/strong> Mr. Rohan Salgarkar<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=infectious-disease-diagnostics-market-worth-315-billion-by-2028-marketsandmarkets\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>1615 South Congress Ave.  Suite 103, Delray Beach, FL 33445<br \/><strong>City:<\/strong> Florida<br \/><strong>State:<\/strong> Florida<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/infectious-disease-diagnostics-market-116764589.html\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/infectious-disease-diagnostics-market-116764589.html<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=infectious-disease-diagnostics-market-worth-315-billion-by-2028-marketsandmarkets\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>North America is well-established, with the US being a major market in this region. This dominance can be attributed to various factors, including advanced healthcare infrastructure, a high prevalence of infectious diseases, and significant investments in diagnostic technologies. Diseases such &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/infectious-disease-diagnostics-market-worth-315-billion-by-2028-marketsandmarkets_734809.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,403,404,416],"tags":[],"class_list":["post-734809","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/734809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=734809"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/734809\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=734809"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=734809"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=734809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}